Programme


Programme

Congress: Programme Day 1
3rd October 2019 (Thursday)

  Diagnostic Track / Topic Highlights
  Hot Topics

FOUNDATION COURSES

Foundation Course 1 (FC 1)
Lecture Hall A, 0730hrs – 0830hrs
Course Objectives:

  • To learn methods of obtaining biopsy specimens when the target is located in a difficult position.
  • To learn on the choice of embolic for hemostatic control and various methods of handling complications during biopsies.

Precision In Targeted Biopsy: How To Optimise Your Biopsies And Handle The Bleed

  • CT-Guided Biopsy: How Do I Do The Dangerous Biopsies With Ease - Anuchit Rhuamthanthong, Thailand
  • Liver Biopsy: Targeting The Difficult Lesions – Tips And Tricks - Ridzuan Abd Rahim, Malaysia
  • Handling Bleed During Biopsies: Gelfoam, Coils, Glue Make It Easy - Rickie Lik-Fai Cheng, Hong Kong, China

Foundation Course 2 (FC 2)
Lecture Hall B, 0730hrs – 0830hrs
Course Objectives:

  1. To understand the basics of ablation for liver tumours and application of different ablation methods for various clinical settings.
  2. To learn how to manage pain in liver ablation.
  3. To learn organ protection techniques during ablation and how to handle complications.

Basics Of Thermal Ablation In Liver

  • Case Selection, Pre-Procedural Preparation And Pain Control (Sedation / GA) - Luan Dinh Nguyen, Vietnam
  • Optimising Zone Of Ablation: Understanding Needle Geometry And Zone Of Ablation / Heat Sink Effect In Radiofrequency Ablation, Microwave Ablation And Cryoablation - TBC
  • Avoidance Of Complication: Needle Track Ablation / Choice Of Organ Protection Technique - Danny Cho, Hong Kong, China

Foundation Course 3 (FC 3)
Lecture Hall C, 0730hrs – 0830hrs
Course Objectives:

  1. To learn the basics of chemoport insertion including technical approach and intra-procedural pain management.
  2. To learn methods of salvaging blocked chemoports.

Chemoport Insertion

  • Indications And Contraindications - Rochan Pant, India
  • Case Preparation And How Do I Do The Sedation / Analgesia - Akkawat Janchai, Thailand
  • Technical Approach & How Do I Do It? - Anushya Vijayananthan, Malaysia
  • How Do I Manage A Failing Chemoport - Shuvro Roy Choudhury, India

FOUNDATION COURSES

Foundation Course 4 (FC 4)
Lecture Hall D, 0730hrs – 0830hrs
Course Objectives:

  1. To recognise when biopsy is needed in cases of bone tumours.
  2. To learn techniques in biopsy of spinal and appendicular bone lesions.
  3. To recognise essential details in MRI evaluation of bone tumours that should be highlighted in the MRI report.

Musculoskeletal Interventions: Back To Basics

  • Don’t Touch Me!! - When Not To Biopsy From The Imaging Perspective - Maizatul Jamny, Malaysia
  • Biopsy Of Spinal Lesions: How Do I Do It? - Muhammad Fadli Embong, Malaysia
  • Biopsy Of Bone Lesions In The Appendicular Skeleton: Pearls And Pitfalls - Marvin T. Tamana, Philippines
  • MSK MRI Evaluation Of Bone Tumours. How Can We Assist The Surgeon? - Maizatul Jamny, Malaysia
  • Bone Tumour Ablation: Pearls And Pitfalls - Hung-Ta Wu, Chinese Taipei

Foundation Course 5 (FC 5)
Lecture Hall F, 0730hrs – 0830hrs
Course Objectives:

  1. To learn the latest FDA guideline in low dose lung cancer screening.
  2. To learn the essentials in CT reporting for low-dose lung cancer screening.
  3. To understand patient selection criteria for low dose lung cancer screening and subsequent management post LDLCS.

Low Dose Lung Cancer Screening (LDLCS): Pitfalls And How Do I Report

  • Lung Cancer Demography, Indications & FDA Guideline In LDLCS - Yong Kek Pang, Malaysia
  • Technical Requirements, Radiation Dose And CT Changes In LDLCS - Zuhanis Abdul Hamid, Malaysia
  • Reporting Standards In LDLCS: LungRAD 2.0 - Zuhanis Abdul Hamid, Malaysia
  • Follow-Up Management In Post LDLCS - Chong Kin Liam, Malaysia

Foundation Course 6 (FC 6)
Lecture Hall E, 0730hrs – 0830hrs
Course Objectives:

  1. To learn the various anatomical variations in hepatic arterial supply, biliary drainage and portal veins that may affect procedures related to these structures.

Fundamentals In Hepatobiliary Interventions

  • Normal Anatomy And Variants Of The Hepatic Arterial Supply – Pearls And Pitfalls For The Young IRs - Izazul Hussin, Malaysia
  • Practical Experiences In Abnormal Feeding Vessels With Difficult Access - Shunsuke Sugawara, Japan
  • Biliary Anatomy Variants And Its Significance In Biliary Stenting - Shunsuke Sugawara, Japan
  • Portal Vein Anatomy And Its Importance In Portal Vein Embolisation - John Sang Joon Park, Korea

MDT ROUND TABLES

MDT Round Table 1 (MDT 1)
Lecture Hall A, 0830hrs – 1000hrs


Hepatocellular Carcinoma 1 : Clinical Assessment Of HCC

  • HCC: What The Hepatologist Sees? - Soek Siam Tan, Malaysia
  • Management Guidelines In HCC: What A Surgeon Follows? The Surgeon’s Perspective / Choice - Boon Koon Yoong, Malaysia
  • Management Stratification In HCC : What An IR Should Know? - Koichiro Yamakado, Japan
  • Downstaging Of Hepatocellular Carcinoma With TACE - Yu- Fan Cheng, Chinese Taipei
  • Phase II Trial Of Sorafenib Combined With On-Demand Transarterial Chemoembolisation For Advanced Stage Hepatocellular Carcinoma (BCLC stage C): STAB Study - Hideyuki Nishiofuku, Japan
  • Case Presentation With Panel Discussion

MDT Round Table 2 (MDT 2)
Lecture Hall D, 0830hrs – 1000hrs


Pain Management In Interventional Oncology

  • Imaging Of Spinal Pain In The Oncology Patient: Benign Versus Malignant Diseases - Roger Tok, Malaysia
  • Managing Pain In A Cancer Patient: Clinical Management Guideline - Gopinathan Raju, Malaysia
  • Sympathetic Nerve Blocks: Indications & Techniques - Miyuki Sone, Japan
  • Oncological Spinal Pain Control: To Burn Or To Freeze? - Naveen Rajadurai, Malaysia
  • Percutaneous Ablation And Cementoplasty Of Painful Osseous Metastatic Disease In Spine - Bui Van Giang, Vietnam
  • Oncological Spinal Pain Control In Metastastic Diseases - Afshin Gangi, France
  • Post Interventional Follow-Up Imaging: How Do I Differentiate Between A Recurent / Residual Disease Versus Inflammatory Changes - Albert Goh, Australia

MDT Round Table 3 (MDT 3)
Lecture Hall A, 1400hrs – 1500hrs


Angiology And Immunology Of HCC

  • Angio-Architecture, Angiosome & Hemodynamic Classifications In HCC: The Impact In A Successful cTACE Shiro Miyayama, Japan
  • Interventional Implications Of Portal Venous Hemodynamic, AV & AP Shunts In HCC Yi-Sheng Liu, Chinese Taipei
  • Pathology In HCC: What The New Immunohistochemistry Entails? Pathmanathan Rajadurai, Malaysia
  • Immunology And Check Point Receptor Researches In HCC TBC, Malaysia

FOCUS WORKSHOPS

Focus Workshop 1 (FW 1)
Lecture Hall B, 0830hrs – 1000hrs


Tumour Ablation 1: Thermal Ablation In Hepatocellular Carcinoma

  • Thermal Ablation For HCC: What’s New In 2019 Hyunchul Rhim, Korea
  • LeVeen™ RFA Needle Electrode: Spherical And Larger Ablation Zone Nutcha Pinjaroen, Thailand
  • RFA In Small HCC: Technical Pitfalls And Literature Reviews Sheng-Nan Lu, Chinese Taipei
  • RFA In Intermediate HCC: Needle Geometry, Case Selection, & Combination Techniques In Optimising Outcome And The Clinical Evidence Peter Goh, Singapore
  • Emprint™ Ablation System With Thermosphere™ Technology In Microwave Ablation: The Confidence Of Spherical Burn Uei Pua, Singapore

Focus Workshop 2 (FW 2)
Lecture Hall B, 1400hrs – 1500hrs


Tumour Ablation 2: Percutaneous Ablation In Lung Tumours

  • Clinical Stratification In Lung Cancer Management: Surgery Versus Focal Ablation - How Do I Decide? Chong Kin Liam, Malaysia
  • Percutaneous Ablation In Primary And Secondary Lung Tumours: What Is The Current Practice? Jean Palussière, France
  • Lung Ablation Is A Safe Procedure: Pitfalls In Avoidance Of Complications Alda Tam, USA
  • Cryoablation In Dangerous Territories: Optimising Carbon Dioxide Dissection And Thermocouple Control Tze Min Wah, United Kingdom

Focus Workshop 3 (FW 3)
Lecture Hall A, 1600hrs – 1800hrs


Conventional TACE In HCC

  • Lipiodol: Biochemistry And Biophysiological Characteristics Of Water In Oil Vs Oil In Water In HCC: From Bench Top To Clinical Applications - Thierry De Baere, France
  • Angiology And Principle Of cTACE For HCC - Yasuaki Arai, Japan
  • Understanding The Principle, Roles, Indications And Contraindications In TACE - SOP Guideline CIRSE 2012: Quality Improvement Guidelines For Hepatic TACE: Strength And Weakness - Yi-Sheng Liu, Chinese Taipei
  • My Secret Invention: Optimising Emulsification Of Lipiodol Mixture - Toshihiro Tanaka, Japan
  • Superselective cTACE In HCC: How Do I Do It? - Shiro Miyayama, Japan
  • AP And AV Shunts In cTACE: How To Handle? - John Sang Joon Park, South Korea
  • Extrahepatic Feeders In HCC: Is It Safe To Embolise And Best Treatment Approach - Hideyuki Nishiofuku, Japan
  • Combined Ablation And cTACE: Technical Feasibility, How Long Do I Wait And Clinical Evidence - Uei Pua, Singapore

FOCUS WORKSHOPS

Focus Workshop 4 (FW 4)
Lecture Hall B, 1600hrs – 1800hrs


Tumor Ablation 3: Advanced Ablation in Oncology

  • Image-Guided Irreversible Electroporation (IRE): The Current Status - Tze Min Wah, United Kingdom
  • EUS-Guided Laser Ablation For Perigastroduodenal Tumours - Tian-An Jiang, China
  • Percutaneous Thermal Ablation: May We Do It Without Percutaneous Puncture? - Jean Palussière, France
  • Role Of Lung Ablation In Recurrent Disease Post Resection Of Primary Lung Tumour - Brian Stainken, USA
  • RFA In Treatment Of Large HCC Adjacent To The Diaphragm - Wei Wu, China
  • Virtual Navigation In Liver Tumour Ablation - Qi-Yu Zhao, China
  • Efficacy And Safety Of Ultrasound-Guided Radiofrequency Ablation Of Parathyroid Nodules For Secondary Hyperparathyroidism - Zhong-Peng Cheng, China
  • The Curative Effect Of Lauromacrogol Sclerosing Therapy For Caesarean Scar Pregnancy - Ming-Kui Li, China
  • Percutaneous Intraductal Chilled Saline Perfusion Assisted Thermal Ablation For Hilum Hepatocellular Carcinoma-What We Can Do If Intrahepatic Bile Duct Is Non-Dilated? - Kai Li, China
  • Early Assessment Of Malignant Liver Lesions After Ablation : A Comparison Of Contrast Enhanced Ultrasound And Contrast-Enhanced MRI - Meng Na He, China

PLENARY SESSIONS

Plenary Sessions
Lecture Hall A, 1000 - 1100hrs

  • Plenary 1: The Journey Of IR In Malaysia - Abdul Samad Sakijan, Malaysia
  • Plenary 2: 4th Pillar In Modern Oncology: Current State-Of-The-Art And Future Innovation In Interventional Oncology -Yasuaki Arai, Japan
  • Plenary 3: Interventional Oncology: A Mainstream Clinical Practice - Andreas Adam, United Kingdom

SPECIAL SESSIONS

Special Session 1
Lecture Hall B, 1200hrs – 1300hrs


Artificial Intelligence In Interventional Oncology

  • Artificial Intelligence In Interventional Radiology: What Does It Entail? - Chih-Horng Wu, Chinese Taipei
  • Artificial Intelligence In Interventional Oncology: How Can It Optimise My Practice? - Kwan Hoong Ng, Malaysia
  • Artificial Intelligence And Virtual Reality: The Way Forward - TBC

SPECIAL SESSIONS

Special Session 2
Lecture Hall E, 1400hrs – 1500hrs


Breast Imaging Workshop

  • Breast Cancer Screening And Diagnosis In High Risk Groups -Kartini Rahmat, Malaysia
  • Contrast-Enhanced Mammography-Guide For Successful Reporting And Interpretation - Maninderpal Kaur, Malaysia
  • Pre-Operative Imaging And Staging Of Breast Cancer - Sharifah Majedah, Malaysia
  • Vascular Architecture Evaluation With Smart 3D Superb Microvascular Imaging Can Improve Specificity And Probably Reduce Unnecessary Biopsy Of BI-RADS Category 4 Breast Masses - Hong-Yan Wang, China

Special Session 3
Lecture Hall D, 1600hrs – 1700hrs

Women In Interventional Oncology

  • RESAIC: Salvage Therapy In Advanced Breast Cancer - Miyuki Sone, Japan
  • Chemo-Radiotherapy In Cervical Cancer Stage 3b: Optimising Outcomes - Anushya Vijayananthan, Malaysia
  • Interventional Embolisation For Uterine Fibroids - Yan-Li Wang, China
  • Liquid biopsy In Precision Medicine: Hype Of The Moment Or Hope Of The Future? - Alda Tam, USA
  • Essential Consideration In Adrenal Gland Ablation - Nancy Shu-Huei Shen, Chinese Taipei

Special Session 4
Lecture Hall D, 1700hrs – 1800hrs

Spine Intervention In Oncology

  • Imaging Pitfalls In Spinal Tumours - Maizatul Jamny, Malaysia
  • Vertebral Augmentation In Malignant Spinal Disorder: Vertebroplasty Vs Kyphoplasty - Albert Goh, Australia
  • Managing Complications In Spine Interventions - Bui Van Giang, Vietnam
  • Cryoablation In Spinal Metastasis - Hung-Ta Wu, Chinese Taipei

Special Session 5
Lecture Hall F, 1600hrs – 1800hrs

Dual Energy MDCT: Principles, Technical Pitalls And Application A

  • Novel Technology Of Iodine Mapping For Liver Lesion (Canon Toshiba Medical) - Wey Chyi Teoh, Singapore
  • Dual Energy In Oncology (Siemens) - Wai Leng Chin, Singapore
  • Next Generation Of Spectral CT And Revolutionary Detection-Based Technology (Philips) - Eric Ting, Singapore

FUTURE IN IOs

Future In IO 1
Lecture Hall D, 1200hrs – 1300hrs


Stem Cell And Immunotherapy Session

  • Stem Cell-Based Cancer Immunotherapy: From Bench Top To Clinical Reality - Shin Yi Tang, Singapore
  • IO x IO: Combining Interventional Oncology And Immuno-Oncology - The Next Frontier In Oncology Management? - Alda Tam, USA
  • Translational Research In IO And Immunology - Haruyuki Takaki, Japan

Future In IO 2
Lecture Hall D, 1400hrs – 1500hrs


Extrahepatic TACE

  • TACE In Mediastinal & Lung Malignancies - Shinichi Hori, Japan
  • TACE In Gynaecological Malignancies (Cervix & Uterus): Indications, Technical Pitfalls And Literature Reviews - Yan-Li Wang, China
  • RADPLAT: The Japan Experience - Miyuki Sone, Japan
  • Superselective Ophthalmic Arterial Chemo Infusion For Retinoblastoma: Promising Technique For Globe Salvage - Suyash Kulkarni, India

NURSE SESSIONS

Nurse Session 1
Lecture Hall E, 0830hrs – 1000hrs


Nursing In Interventional Radiology: An Overview

  • Tumour Nursing Team: Past, Present And Future - Ren-Jie Yang, China
  • Brief Introduction To The Developing Of Interventional Nursing Organisation In China - Mei-Qi Wu, China
  • Challenges In Setting Up An Interventional Radiology Nursing Service In Public Hospital: The Malaysian Experience - Jassmien Elmie Jamaludin, Malaysia
  • How To Prepare A Patient For VIR Procedure - Nurazliza Kawi, Malaysia
  • Teamwork In IR: Doing It The HKL Way - Ruzimah Mohamed @ Mahmood, Malaysia

Nurse Session 2
Lecture Hall E, 1200hrs – 1300hrs


Nursing In IR: The Essentials Part 1

  • What A VIR Nurse Is Expected To Do? - TBC
  • Application And Perioperative Nursing Of Y-Type Covered Stent In Interventional Operation Of Thoracostomach-Airway Fistula - Xiao Li, China
  • Image Guided Percutaneous Biopsies: Roles And Duties Of VIR Nurses - Dhashinee Gopal, Malaysia
  • Nursing Care For Patients With Pulmonary Nodules Locating By Spring Coil - Yue Gao, China

MORBIDITY AND MORTALITY

Morbidity And Mortality 1 (M&M 1)
Lecture Hall C, 1600hrs – 1800hrs


My Worse Nightmare

  • Case Presentations With Learning Objectives (Bad Outcome)
  • Case Presentations With Learning Objectives (Good Outcome)

ASIA PACIFIC c-TACE CHALLENGE

Asia Pacific c-TACE Challenge By Guerbet
Lecture Hall E, 1600hrs – 1800hrs


  • Case Presentations

APCIO MEETS SIO

APCIO MEETS SIO
Lecture Hall A, 1200hrs – 1300hrs


  • Evolution Of Interventional Oncology And The Global Vision Of Society Of Interventional Oncology (SIO) - Uei Pua, Singapore
  • IO As A Subspecialty And Our Path Forward - TBC
  • Preoperative Liver Regeneration Strategies To Improve The Safety Of Major Hepatic Resection: Which One And When? - David C. Madoff, USA

LIVE CASE TRANSMISSIONS

Live Transmission 1
Lecture Hall C, 0900hrs – 1000hrs


Liver Case HCC cTACE
Primary Operator: Shiro Miyayama, Japan

Live Transmission 2
Lecture Hall C, 1500hrs – 1600hrs


Cryoablation
Primary Operator: Afshin Gangi, France

EXTREME IO CASE CHALLENGES

Extreme IO Case Challenge Session 1
Lecture Hall C, 0830hrs – 0900hrs

Case Presentations & Discussion

Extreme IO Case Challenge Session 2
Lecture Hall C, 1200hrs – 1300hrs

Case Presentations & Discussion

Extreme IO Case Challenge Session 3
Lecture Hall C, 1400hrs – 1500hrs

Case Presentations & Discussion

LUNCH SYMPOSIUMS

Lunch Symposium By Canon Medical
Lecture Hall A, 1300hrs - 1400hrs


The Power Of Angio-CT: Seeing The Unseen

  • Technological Innovation And The Future Of Angio-CT In Interventional Oncology - Yasuaki Arai, Japan
  • Value-Added Benefits Of Angio-CT In Maximising IO Services - Shunsuke Sugawara, Japan
  • New Concepts In Interventional Oncology: The Power Of Angio-CT In Game Planning, Outcome Prediction, Region At Risk, 3D Visualisation, 3D Safety Margin, Embolic Density And Detection Of Complications - Alex Tang, Malaysia

Lunch Symposium By Boston Scientific
Lecture Hall B, 1300hrs - 1400hrs


“Meet The Masters”

  • Cryoablation In Interventional Oncology: Transcending The Limits In Cancer Management - Afshin Gangi, France
  • DEBIRI In Colorectal Cancer Liver Metastases - Toshihiro Tanaka, Japan
  • Therasphere® In Radioembolisation Of Hepatocellular Carcinoma - Matthew Johnson, USA

BOOTH SYMPOSIUMS

Booth Tea Symposium By Boston Scientific
1500hrs - 1600hrs

  • Galil Medical Cryoablation Needles - Peter Goh, Singapore

Booth Tea Symposium By Canon Medical
1500hrs - 1600hrs

  • Introduction Of Alphenix Line Up - Yoshimichi Ami
  • How Are You Doing With Canon 4DCT - James Tan